newsfilter
← Latest News
GlobeNewswire·

Aeterna Zentaris and Ceapro Announce Merger of Equals to Create a Diversified Biopharmaceutical Company

TORONTO and EDMONTON, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX:AEZS) ("Aeterna") and Ceapro Inc. (TSXV:CZO) (OTCQX:CRPOF) ("Ceapro"), two innovative biopharmaceutical development